SRI Biosciences will be at the Society of Toxicology (SOT) ToxExpo March 17-20th in Orlando! Stop by booth 503 to learn about our toxicology and pharmacology services, as well as other unique preclinical R&D offerings. Learn more about us: https://lnkd.in/e-Mq3JBX #2025SOT #ToxExpo #drugdevelopment
SRI Biosciences
生物技术研究
Menlo Park,California 1,134 位关注者
Developing next-gen drugs, diagnostics, and technologies to solve unmet medical needs and propel innovation to market.
关于我们
- 网站
-
https://www.sri.com/biomedical-sciences/
SRI Biosciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Menlo Park,California
- 领域
- drug discovery、drug development、formulation development、pharmacology/toxicology、medicinal chemistry、automated chemical synthesis、neuroscience、human sleep research、proteomics、diagnostics、immuno-oncology、targeted drug delivery、intracellular drug delivery、nucleic acid delivery、biological assay development、high-throughput screening、CRISPR、medical imaging、virology和nonclinical development
动态
-
The next SRI PARC Forum is taking place Friday, March 7th 2-3pm PT. You can still register for the live stream below to tune in to a conversation between SRI CEO David Parekh and Eric Schmidt, former Google CEO, as he delves into AI’s societal and ethical implications.
Join us online for our next PARC Forum on March 7! SRI CEO David Parekh and Eric Schmidt – former Google CEO and a leading voice on AI's impact on humanity – will discuss insights and stories from Schmidt's new book around AI’s critical role in national security, ethical and trust issues, and the essential role of humans in guiding innovation in the 21st century. The in-person event is sold out - register for our live stream here: https://hubs.ly/Q0352tRZ0
-
-
“One of the industries that can take the best advantage of SRI is life sciences, where our multi-disciplinary capabilities can really help them achieve their goals,” said Peter Marcotullio, Sr. Vice President of Commercialization. Listen as Peter discusses how we're bringing cutting-edge technology to the world and helping our customers solve their biggest problems across various fields, including life sciences. https://lnkd.in/gXVNY3MY #lifesciences #research #precisionmedicine
-
SRI Biosciences has developed a platform — called DiaCyt — to identify peptides that can deliver a wide variety of therapeutics to targets across the blood brain barrier. DiaCyt enables systemic, intracellular delivery of cargos to targeted cells such as neurons, microglia and DRGs. We’re actively seeking commercial partners for this platform. Learn more and contact us: https://lnkd.in/eSct4AYx #precisionmedicine #therapeutics #drugdelivery
-
-
An SRI-led team has succeeded in creating a food product rich in essential nutrients, suitable for quickly scaling up disaster relief in remote locations. “The team is developing a deployable food delivery system that creates enough food to feed 14 people per day for over a month,” said Elisabeth Perea, principal investigator and senior chemical engineer at SRI. Ready the story: https://lnkd.in/ebeXF96w Air Protein | Kiverdi, Inc. | Defense Advanced Research Projects Agency (DARPA) #bioengineering #bioprocess
-
-
SRI’s Targeted Antigen Loaded Liposomes (TALL) is a novel immunotherapy that can aid in turning a cold tumor to hot — enabling a higher response rate in tumors resistant to immunooncology-therapies. We are actively seeking commercial partners for this platform that recently earned FDA orphan drug designation for pancreatic cancer. Learn more and reach out here: https://lnkd.in/e2p-X9va #immunotherapy #precisionmedicine #pancreaticcancer
-
-
Did you know SRI has a Clinical Trials Unit (CTU) located in Plymouth, Michigan? Our CTU can support phase I through IV trials in several therapeutic areas including neurology, respiratory, anesthesiology, sleep disorders, pain, vaccines, and more. We have availability to support studies in these areas in 2025. Learn more about our site: https://lnkd.in/etAJHS3m #clinicaltrials #clinicalresearch #clinicalsite
-
-
Learn more and register for the next SRI PARC Forum on March 7th ?? #innovation #ai
Register now for our next PARC Forum with Eric Schmidt – technologist, entrepreneur, philanthropist, and former Google CEO – in a conversation with David Parekh, CEO of SRI, as they delve into AI’s societal and ethical implications. Join our event to engage with one of the world's leading voices on AI's impact on humanity, and hear insights and stories from Schmidt's new book around AI’s critical role in national security, ethical and trust issues, and the essential role of humans in guiding innovation in the 21st century. Register early to secure your seat! https://hubs.ly/Q0352tRZ0
-
-
SRI has been a leader for decades in the development of tools, technologies, and therapeutics that have saved and improved countless lives around the world. Our Biosciences division works with government and commercial clients to integrate basic and translational research, drug discovery, and nonclinical and clinical development. Learn about how we’re innovating in health and connect with us: https://lnkd.in/eegk_faF #precicionmedicine #drugdiscovery #biomedical
-
-
On a recent episode of Herself Health podcast, SRI's Human Sleep Research Program Director, Fiona Baker, addresses questions on sleep differences between men and women, how our partners impact our sleep, what to do about sleep disturbances, and more — and shares on how we can improve our sleep to set ourselves up for a successful day. Listen here: https://lnkd.in/ea8PawnV #womenshealth #sleep